不応性急性骨髄性白血病:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Refractory Acute Myeloid Leukemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Refractory Acute Myeloid Leukemia to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Refractory Acute Myeloid Leukemia to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Refractory Acute Myeloid Leukemia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Refractory Acute Myeloid Leukemia 32
Mar 12, 2014: Cornerstone Pharmaceuticals Lead Compound CPI-613 Demonstrates Ability to Disrupt Growth of Cancer Cells 32
Jun 25, 2013: FDA Issues Partial Clinical Hold On Cell Therapeutics’s Tosedostat For Treatment Of Blood Cancer 32
Jun 13, 2013: Sunesis Pharma Announces Data And Safety Monitoring Board Recommends Continuation Of VALOR Trial With No Change To Study Conduct 33
Apr 01, 2013: Clavis Pharma Reports Negative Outcome Of Phase III CLAVELA Trial With Elacytarabine In Patients With Acute Myeloid Leukemia 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Celgene Corporation 38
Clinical Trial Overview of Celgene Corporation 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
C. H. Boehringer Sohn AG & Co. KG 40
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 40
Ambit Biosciences Corporation 41
Clinical Trial Overview of Ambit Biosciences Corporation 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
AROG Pharmaceuticals LLC 43
Clinical Trial Overview of AROG Pharmaceuticals LLC 43
Amgen Inc. 44
Clinical Trial Overview of Amgen Inc. 44
AbbVie Inc. 45
Clinical Trial Overview of AbbVie Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
Fred Hutchinson Cancer Research Center 49
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 49
Children’s Oncology Group 50
Clinical Trial Overview of Children’s Oncology Group 50
The University of Texas M. D. Anderson Cancer Center 51
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 51
Stanford University 52
Clinical Trial Overview of Stanford University 52
Washington University School of Medicine 53
Clinical Trial Overview of Washington University School of Medicine 53
Roswell Park Cancer Institute 54
Clinical Trial Overview of Roswell Park Cancer Institute 54
Sidney Kimmel Comprehensive Cancer Center 55
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 55
Case Comprehensive Cancer Center 56
Clinical Trial Overview of Case Comprehensive Cancer Center 56
Five Key Clinical Profiles 57
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120


【レポート販売概要】

■ タイトル:不応性急性骨髄性白血病:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2081CTIDB
■ 調査対象地域:グローバル
  • 交通管理の世界市場予測(~2023年)
    Factors such as high demographic growth and hyper-urbanization in the developing countries and the government initiatives for traffic management under smart cities models are some of the factors driving the traffic management marketThe traffic management market is expected to grow from USD 26.7 billion in 2018 to USD 50.7 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 13.7%. The marke …
  • フードサービス用手袋の世界市場2017-2021:使い捨て手袋
    About Foodservice Gloves The growth of the foodservice disposable gloves segment can be attributed mainly to the enhanced features of raw materials used in manufacturing these gloves. For instance, some of the market players such as Omni International and Emerald Latex Gloves Company provide vinyl gloves, which have anti-microbial property. This helps reduce the risk of cross contamination in food …
  • 飼料用非蛋白性窒素(NPN)の世界市場予測(~2020)
    The feed non-protein nitrogen market is projected to grow at a CAGR of 4.5% from 2015 to reach a projected value of USD 1.65 Billion by 2020. In terms of volume, the feed non-protein nitrogen market is projected to reach 3,374.1 KT by 2020 from an estimated volume of 2,725.8 KT in 2015. The market growth is driven by increasing livestock population. The market is further driven by factors such as …
  • 臓器保存の世界市場:ソリューション、技術、臓器種類、地域別分析
    The organ preservation market is expected to reach USD 241.2 Million in 2021 from USD 165.9 Million in 2016 at a CAGR of 7.8%. The demand for organ preservation solutions and transport devices has been on the rise due to the growing organ transplants across the globe and better transplant outcomes for end-stage diseases. The technological advancements in the organ preservation technique have enabl …
  • 分子細胞遺伝学の世界市場予測(~2021):製品別(キット、試薬、プローブ、消耗品、ソフトウェア、サービス)、技術別(ハイブリダイゼーション法(In-Situ)、蛍光染色体ハイブリッド形成(FISH)、比較ゲノムハイブリダイゼーション)、用途別(がん、遺伝)、エンドユーザー別(研究室、研究機関)
    The molecular cytogenetics market is projected to reach USD 2.52 billion by 2021 from USD 1.55 billion in 2016, at a CAGR of 10.1% from 2016 to 2021. The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region. The kits and reagents segment is expected to register the highest growth rate in the molecular cytogenetics market, by product, duri …
  • 2014年戦略提言:フランスの臨床化学・免疫診断市場
    Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Strategies for the French Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the French clinical chemistry and immunodiagnostic markets during the next five years.  The report explores future trends in the French market …
  • グルテンミート(セイタン)の世界市場2019-2023
    About this market The increasing demand for ready-to-eat food products to drive growth in the market. demand for convenience in food products has fueled the demand for ready-to-eat food products, including seitan. The need for leisure time has increased the demand for convenience food products among consumers. Thus. ready-to-eat food items are gaining popularity among time-pressed consumers. Techn …
  • 世界のSoftware-Defined Network(SDN)市場展望(~2018)
    The software-defined networking (SDN) is a burgeoning industry and it exhibits immense potential for growth in coming years. Factors such as rising need for mobility across enterprises, an efficient network of infrastructure and declining cost of network maintenance & operations through SDN deployment are driving the growth of the SDN market. Considering these, the market is slated to grow at a CA …
  • Sepsis:グローバル臨床試験レビューH2, 2013
    Sepsis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2013" provides data on the Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sepsis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
  • 産業用ポータブルキャリブレータ―の世界市場2018-2022
    About Industrial Portable Calibrators Portable calibrators are handheld devices used to measure the measure the measurement accuracy of field instruments by comparing the readings with the industry measurement standards. These lightweight devices can be easily carried because of their compact size. Technavio’s analysts forecast the global industrial portable calibrators market to grow at a CAGR of …
  • 世界のFPGA(フィールドプログラマブルゲートアレイ)市場2015
    The Global Field-Programmable Gate Array (FPGA) Industry Report 2015 is a professional and in-depth study on the current state of the Field-Programmable Gate Array (FPGA) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Field-Programmable Gate Array (FPGA) market analysis is provided for the intern …
  • AEC(建築・工学・建設)ソリューションの世界市場2016-2020
    About the Architectural Engineering and Construction Market AEC solutions include both software and services for the construction of large and complex residential, industrial, and commercial buildings. It includes features such as designing, building, operations, and management. The major end-users of AEC solutions include architects, engineers, and contractors. There is widespread adoption of AEC …
  • GTL(Gas to Liquids)のグローバル市場動向
    In the wake of the rising pollution levels due to the emissions traditionally associated with conventional petroleum-fuelled and diesel-fuelled vehicles, Gas to liquids technology is forecast to advance rapidly. Gas to liquids technology (GTL) provides crystal clear fuels that can dramatically improve air quality in the major metropolitan areas of the world. GTL uses natural gas as a raw material …
  • 世界のパッケージソフト市場動向(2012-2016)
    TechNavio's analysts forecast the Global Packaged Software market to grow at a CAGR of 6.93 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in IT spending by BRIC nations. The Global Packaged Software market has also been witnessing the increasing demand for tablets and smartphones. However, the increasing demand for open-source, third-p …
  • びまん性大細胞型B細胞性リンパ腫:世界の臨床試験レビュー(2014年上半期)
    Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Diffuse Large B-Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. It includes an overv …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。